Synthesis of bis-1,2,3-triazolo-bridged unsymmetrical pyrrolobenzodiazepine trimers via ‘click’ chemistry and their DNA-binding studies
暂无分享,去创建一个
Ahmed Kamal | G. Narahari Sastry | Hemant Kumar Srivastava | Nagula Shankaraiah | H. K. Srivastava | G. N. Sastry | S. Prabhakar | N. Shankaraiah | A. Kamal | N. Markandeya | Sripadi Prabhakar | Ch. Ratna Reddy | Nagula Markandeya | C. R. Reddy
[1] L. Hurley,et al. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. , 1977, The Journal of antibiotics.
[2] Chi‐Huey Wong,et al. A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry , 2003 .
[3] L. Hurley. DNA and associated targets for drug design. , 1989, Journal of medicinal chemistry.
[4] S. Neidle,et al. Synthesis of Sequence-Selective C8-Linked Pyrrolo[2,1-c][1,4]benzodiazepine DNA Interstrand Cross-Linking Agents. , 1996, The Journal of organic chemistry.
[5] Alan R. Katritzky,et al. Comprehensive Heterocyclic Chemistry IV , 1996 .
[6] A. Kamal,et al. Synthesis and DNA-binding ability of pyrrolo[2,1-c][1,4]benzodiazepine-azepane conjugates. , 2006, Bioorganic & medicinal chemistry letters.
[7] R. Souhami,et al. Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents. , 1994, British Journal of Cancer.
[8] S. Prabhakar,et al. Synthesis of C8–C8/C2–C8-linked triazolo pyrrolobenzodiazepine dimers by employing ‘click’ chemistry and their DNA-binding affinity , 2008 .
[9] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[10] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[11] L. Hurley,et al. Comparison of a DSB-120 DNA interstrand cross-linked adduct with the corresponding bis-tomaymycin adduct: an example of a successful template-directed approach to drug design based upon the monoalkylating compound tomaymycin. , 1994, Journal of medicinal chemistry.
[12] L. Hurley,et al. Proposed structure of the anthramycin–DNA adduct , 1979, Nature.
[13] M. Berardini,et al. Effect of linker length on DNA-binding affinity, cross-linking efficiency and cytotoxicity of C8-linked pyrrolobenzodiazepine dimers , 1992 .
[14] M. Tendler,et al. ‘Refuin’ : a Non-cytotoxic Carcinostatic Compound proliferated by a Thermophilic Actinomycete , 1963, Nature.
[15] David S Goodsell,et al. Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors , 2003, Chembiochem : a European journal of chemical biology.
[16] M. G. Finn,et al. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. , 2001, Angewandte Chemie.
[17] S. Sen,et al. Design, Synthesis and Biological Activity of A-C8/C-C2-Linked 6-Chloropurine-Pyrrolobenzodiazepine Hybrids as Anticancer Agents , 2007 .
[18] N. Heindel,et al. 4‐Amino‐3‐mercapto‐4H‐1,2,4‐triazoles and propargyl aldehydes: A new route to 3‐R‐8‐aryl‐1,2,4‐triazolo[3,4‐b]‐1,3,4‐thiadiazepines , 1980 .
[19] S. Sen,et al. 1,2,4-benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity. , 2007, Bioorganic & medicinal chemistry letters.
[20] C. Hawker,et al. Dendronized linear polymers via "click chemistry". , 2004, Journal of the American Chemical Society.
[21] Hemant Kumar Srivastava,et al. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents. , 2010, Bioorganic & medicinal chemistry.
[22] Federico G. De las Heras,et al. Alkylating nucleosides 1. Synthesis and cytostatic activity of N-glycosyl(halomethyl)-1,2,3-triazoles. A new type of alkylating agent. , 1979 .
[23] Ó. Lopéz,et al. Click Chemistry - What’s in a Name? Triazole Synthesis and Beyond , 2007 .
[24] A. Kamal,et al. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity. , 2002, Journal of medicinal chemistry.
[25] S. Neidle,et al. Structure of a covalent DNA minor groove adduct with a pyrrolobenzodiazepine dimer: evidence for sequence-specific interstrand cross-linking. , 1994, Journal of medicinal chemistry.
[26] J. Hartley,et al. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers. , 2004, Journal of medicinal chemistry.
[27] David A. Kofke,et al. Accuracy of free-energy perturbation calculations in molecular simulation. II. Heuristics , 2001 .
[28] E. Müller. Methoden der organischen Chemie (Houben-Weyl) , 1952 .
[29] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[30] Craig J Hawker,et al. Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(i)-catalyzed ligation of azides and alkynes. , 2004, Angewandte Chemie.
[31] N. Shankaraiah,et al. A facile intramolecular azido/amido reductive cyclization approach: synthesis of pyrrolobenzodiazepines and their dimers , 2008 .
[32] Qian Wang,et al. Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.
[33] M. Waring,et al. DNA modification and cancer. , 1981, Annual review of biochemistry.
[34] A. Kamal,et al. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates. , 2007, Bioorganic & medicinal chemistry.
[35] M. Berardini,et al. Rational design of a highly efficient irreversible DNA interstrand cross-linking agent based on the pyrrolobenzodiazepine ring system , 1992 .
[36] Yoav Eichen,et al. Directed DNA metallization. , 2006, Journal of the American Chemical Society.
[37] Richard A. Friesner,et al. Solvation Free Energies of Peptides: Comparison of Approximate Continuum Solvation Models with Accurate Solution of the Poisson−Boltzmann Equation , 1997 .
[38] G. N. Sastry,et al. Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo[2,1-c][1,4]benzodiazepines and their anticancer potential. , 2009, Bioorganic & medicinal chemistry.
[39] M. Waring,et al. Molecular Aspects of Anticancer Drug/DNA Interactions , 1993 .
[40] M. Walton,et al. Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120 , 1996, Cancer Chemotherapy and Pharmacology.
[41] Alfonso R. Gennaro,et al. Remington:the science and practice of pharmacy , 1995 .
[42] David A. Kofke,et al. Accuracy of free-energy perturbation calculations in molecular simulation. I. Modeling , 2001 .
[43] N. Shankaraiah,et al. An efficient solid-phase synthesis of biologically important DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepine dimers (DSB-120) and their C2-fluorinated analogues , 2006 .
[44] S. Lippard,et al. Structural aspects of platinum anticancer drug interactions with DNA , 1987 .
[45] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[46] Ahmed Kamal,et al. Synthesis of 1,2,3-triazole-linked pyrrolobenzodiazepine conjugates employing 'click' chemistry: DNA-binding affinity and anticancer activity. , 2008, Bioorganic & medicinal chemistry letters.
[47] Christopher I. Bayly,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..
[48] M. Tang,et al. CONCERNING IN VITRO MITOMYCIN-DNA ALKYLATION , 1996 .
[49] A. Kamal,et al. Solid-phase synthesis of new pyrrolobenzodiazepine-chalcone conjugates: DNA-binding affinity and anticancer activity. , 2008, Bioorganic & medicinal chemistry letters.